{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:57:45Z","timestamp":1767142665964,"version":"build-2238731810"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GSK, The Netherlands"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12471-016-0849-z","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T20:35:27Z","timestamp":1463690127000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands"],"prefix":"10.1007","volume":"24","author":[{"given":"M.","family":"Wapenaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Twiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wagenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Seijkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"van den Toorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stepanous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Boomars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"849_CR1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery J\u2011L, et al. ERS\/ESC guidelines. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015;46:903\u2013975.","journal-title":"Eur Respir J"},{"key":"849_CR2","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","volume":"62","author":"MD McGoon","year":"2013","unstructured":"McGoon MD, Benaz RL, Escribano-Scubias P, et al. Pulmonary Arterial Hypertension. Epidemiology and Registries. J Am Coll. 2013;62:D51\u2013D59.","journal-title":"J Am Coll"},{"key":"849_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","volume":"142","author":"RL Benza","year":"2012","unstructured":"Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from the time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest. 2012;142:448\u2013456.","journal-title":"Chest"},{"key":"849_CR4","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","volume":"62","author":"N Kim","year":"2013","unstructured":"Kim N, Delcroix M, Jenkins DP, et\u00a0al. Chronic Thomboembolic Pulmonary Hypertension. J\u00a0Am Coll Cardiol. 2013;62:D92\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"849_CR5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12471-014-0592-2","volume":"22","author":"BE Sch\u00f6lzel","year":"2014","unstructured":"Sch\u00f6lzel BE, Snijder RJ, Mager JJ, et\u00a0al. Chronic thromboembolic pulmonary hypertension. Neth Heart J. 2014;22:533\u2013541.","journal-title":"Neth Heart J"},{"key":"849_CR6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1378\/chest.126.5.1452","volume":"126","author":"S Shafazand","year":"2004","unstructured":"Shafazand S, Goldstein MK, Doyle RL, et al. Health-Related Quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126:1452\u20131459.","journal-title":"Chest"},{"key":"849_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpsychores.2008.09.014","volume":"66","author":"KL Looper","year":"2009","unstructured":"Looper KL, Pierre A, Dunkley DM, et\u00a0al. Depressive symptoms in relation to physical functioning in pulmonary hypertension. J\u00a0Psychosom Res. 2009;66:221\u2013225.","journal-title":"J Psychosom Res"},{"key":"849_CR8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.healun.2014.04.003","volume":"33","author":"J Vanhoof","year":"2014","unstructured":"Vanhoof J, Delcroix M, Vanvelde E, et\u00a0al. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J\u00a0Heart Lung Transplant. 2014;33:800\u2013808.","journal-title":"J Heart Lung Transplant"},{"issue":"339-339","key":"849_CR9","first-page":"e8","volume":"51","author":"D McCollister","year":"2010","unstructured":"McCollister D, Beutz M, McLaughlin V, et al. Depressive symptoms in pulmonary hypertension: prevalence and association with functional status. Psychosomatics. 2010;51(339-339):e8.","journal-title":"Psychosomatics"},{"key":"849_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, Boer M de, et\u00a0al. Quality criteria were proposed for measurement properties of health status questionnaires. J\u00a0Clin Epidemiol. 2007;60:34\u201342.","journal-title":"J Clin Epidemiol"},{"key":"849_CR11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","volume":"40","author":"O Sitbon","year":"2002","unstructured":"Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002;40:780\u2013788.","journal-title":"J Am Coll Cardiol"},{"key":"849_CR12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","volume":"106","author":"VV McLaughlin","year":"2002","unstructured":"McLaughlin VV, Shillington A, Rich S, et\u00a0al. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002;106:1477\u20131482.","journal-title":"Circulation"},{"key":"849_CR13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","volume":"28","author":"RJ Barst","year":"2006","unstructured":"Barst RJ, Galie N, Naeije R, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous trepostenil. Eur Respir J. 2006;28:1195\u20131203.","journal-title":"Eur Respir J"},{"key":"849_CR14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12471-015-0666-9","volume":"23","author":"IM Blok","year":"2015","unstructured":"Blok IM, Riel ACMJ van, Schuuring MJ, et\u00a0al. Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease. Neth Heart J. 2015;23:278\u2013284.","journal-title":"Neth Heart J"},{"key":"849_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","volume":"15","author":"SP McKenna","year":"2006","unstructured":"McKenna SP, Doughty N, Meads DM, et\u00a0al. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). A\u00a0measure of health related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15:103\u2013115.","journal-title":"Qual Life Res"},{"key":"849_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1477-7525-11-31","volume":"11","author":"H Chen","year":"2013","unstructured":"Chen H, Rosenzweig E, Gotzkowsky SK, et\u00a0al. Treatment satisfaction is associated with improved quality of life in patients treated with inhaled trepostenil for pulmonary arterial hypertension. Health Qual Life Outcomes. 2013;11:31.","journal-title":"Health Qual Life Outcomes"},{"key":"849_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.12-0993","volume":"143","author":"L Chan","year":"2013","unstructured":"Chan L, Chin L, Kennedy M, et\u00a0al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143:333\u2013343.","journal-title":"Chest"},{"key":"849_CR18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1378\/chest.12-2443","volume":"144","author":"C McCabe","year":"2013","unstructured":"McCabe C, Bennet M, Doughty N, et al. Patient-reported outcomes assessed by CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest. 2013;144:522\u2013530.","journal-title":"Chest"},{"key":"849_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1155\/2008\/767126","volume":"15","author":"D Coffin","year":"2008","unstructured":"Coffin D, Duval K, Martel S, et al. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review into French-Canadian and English-Canadian. Can Respir J. 2008;15:77\u201383.","journal-title":"Can Respir J"},{"key":"849_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.healun.2007.10.004","volume":"27","author":"D Coffin","year":"2008","unstructured":"Coffin D, Duval K, Martel S, et\u00a0al. United States Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAPMHOR. J\u00a0Heart Lung Transplant. 2008;27:124\u2013130.","journal-title":"J Heart Lung Transplant"},{"key":"849_CR21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1440-1843.2011.02030.x","volume":"16","author":"L Ganderton","year":"2011","unstructured":"Ganderton L, Jenkins S, McKenna S, et\u00a0al. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population. Respirology. 2011;16:1235\u20131240.","journal-title":"Respirology"},{"key":"849_CR22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1477-7525-10-110","volume":"10","author":"K Cima","year":"2012","unstructured":"Cima K, Twiss J, Speich R, et\u00a0al. The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR. Health Qual Life Outcomes. 2012;10:110\u2013118.","journal-title":"Health Qual Life Outcomes"},{"key":"849_CR23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1403494812464445","volume":"40","author":"N Selmovic","year":"2012","unstructured":"Selmovic N, Rundqvist B, Kjork E, et\u00a0al. Adaptation and validation of the Cambridge pulmonary hypertension review for Sweden. Scand J Public Health. 2012;40:777\u201383.","journal-title":"Scand J Public Health"},{"key":"849_CR24","doi-asserted-by":"crossref","unstructured":"Hunt SM, McKenna SP, McEwen J, et\u00a0al. The Nottingham Health Profile: Subjective Health Status and Medical Consultations. Soc Sci Med A;15A;221\u20139.","DOI":"10.1016\/0271-7123(81)90005-5"},{"key":"849_CR25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2466\/pr0.1993.72.3.1027","volume":"72","author":"RAM Erdman","year":"1993","unstructured":"Erdman RAM, Passchier J, Kooijman M, et\u00a0al. The Dutch version of the Nottingham Health Profile: investigations of psychometric aspects. Psychol Rep. 1993;72:1027\u20131035.","journal-title":"Psychol Rep"},{"key":"849_CR26","first-page":"523","volume-title":"Foundations of Clinical Research: Applications to Practise","author":"L Portney","year":"2009","unstructured":"Portney L, Watkins M. Correlation. In: Cohen M, editor. Foundations of Clinical Research: Applications to Practise, 3rd\u00a0edn. New Jersey: Pearson Education; 2009. pp.\u00a0523\u2013538.","edition":"3"}],"updated-by":[{"DOI":"10.1007\/s12471-018-1158-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000}}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-016-0849-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-016-0849-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-016-0849-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-016-0849-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:17:28Z","timestamp":1553613448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-016-0849-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1007\/s12471-016-0849-z","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}